%0 Journal Article
%T 肺腺鳞癌的临床特征、分子特征及预后<br>Clinical Features, Molecular Features and Prognosis of Lung Adeno-Squamous Cell Car-cinoma
%A 孙尚莹
%A 赵征
%A 马婕群
%A 郑琪
%A 高芝兰
%A 张科宇
%J Advances in Clinical Medicine
%P 1770-1776
%@ 2161-8720
%D 2023
%I Hans Publishing
%R 10.12677/ACM.2023.132245
%X 肺腺鳞癌是由腺癌和鳞癌两种混合成分构成的一种比较罕见的肺癌类型，它的发病率比较低，仅占肺癌的0.4%~4%，肺腺鳞癌具有与肺腺癌和肺鳞癌相似的生物学特征，但其早期发现和诊断比较困难，容易侵袭周围组织和远处转移，预后也不理想。目前，随着基因检测技术的逐渐成熟，以EGFR-TKIs为代表的靶向治疗和以PD-L1免疫检查点抑制剂为代表的免疫治疗临床应用显著延长了肺腺鳞癌患者的生存时间。对肺腺鳞癌特征的深入研究，有助于为临床诊疗提供更多的方法和思路，实施精准化治疗，更好地改善患者的预后。<br />
Adenosquamous carcinoma of lung is a rare type of lung cancer composed of adenocarcinoma and squamous cell carcinoma. Its incidence is relatively low, accounting for only 0.4% to 4% of lung cancer. However, adenosquamous cell carcinoma of lung has similar biological characteristics to those of adenocarcinoma and squamous cell carcinoma of lung, but its early detection and diagnosis are difficult, easy to invade surrounding tissues and distant metastasis, and its prognosis is not ide-al. At present, with the gradual maturation of gene detection technology, the clinical application of targeted therapy represented by EGFR-TKIs and immunotherapy represented by PD-L1 immune checkpoint inhibitors has significantly prolonged the survival time of lung adenosquamous cell car-cinoma patients. In-depth study on the characteristics of lung adenosquamous cell carcinoma is helpful to provide more methods and ideas for clinical diagnosis and treatment, implement precise treatment, and better improve the prognosis of patients.
%K 肺腺鳞癌，临床特征，分子特征，预后<br>Lung Adenosquamous Carcinoma
%K Clinical Features
%K Molecular Characteristics
%K Prognosis
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=61321